Table 3.
Anthropometric and Metabolic Parameters in the Two Study Groups after the Trial
| characterstrics | Control Diet (n=22) | GFD Diet (n=23) | P-valuea |
|---|---|---|---|
| Weight (kg) | 80.45±15.09b | 77.54± 8.98 | 0.171 |
| BMI (kg/m2) | 30.8± 4.1 | 30.1± ± 3.64 | 0.058 |
| WC (cm) | 101.23±5.97 | 101.73±9.13 | 0.001 |
| FBS (mg/dl) | 120.15±37.28 | 110.86±26.45 | 0.003 |
| Insulin serum (mU/L) | 14.45±7.26 | 12.38±6.37 | 0.619 |
| HOMA score | 12.36±6.85 | 10.19±6.37 | 0.153 |
| Serum Lipids | |||
| Total cholestrol (mg/dl) | 163.75±38.28 | 167.65±30.95 | 0.465 |
| HDL (mg/dl) | 45.89±14.80 | 48.26±8.41 | 0.745 |
| Triglycerides (mg/dl) | 154.75±41.31 | 138.52±42.13 | 0.032 |
| LDL (mg/dl) | 93.91±36.57 | 97.21±9.13 | 0.185 |
| Blood pressure | |||
| Systolic (mmHg) | 13.87±1.01 | 13.67±1.06 | 0.539 |
| Diastolic (mmHg) | 8.32±.50 | 8.67±.59 | 0.328 |
WC, waist circumference; FBS, fasting blood sugar; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low density lipoprotein; HDL-C, high-density lipoprotein cholesterol; CI, confidence interval; ANOVA, analysis of variance;
a
Based on an ANOVA model that regressed changes from baseline on treatment group, baseline value of the outcome;
b
Mean ± SD (all such values).